Your Growth Factors. Purified. Amplified. Returned.
Beyond PRP. Same Blood. Greater Precision. — GFC takes the biological principle behind PRP and advances it through a more precise preparation process — activating and lysing platelets in the laboratory to release their entire growth factor payload, then concentrating the purified supernatant. The result is a more potent, more consistent, and more clinically productive biological treatment for skin rejuvenation, acne scar revision, and post-procedure recovery.
Overview
PRP established the clinical case for autologous growth factor therapy clearly: the growth factors concentrated in platelets — the same molecules the body deploys to repair tissue after injury — can be isolated from a small blood draw, concentrated beyond their normal circulating levels, and reintroduced into the skin to stimulate a regenerative response that produces measurable improvements in skin quality, texture, and tone. The evidence is extensive. The mechanism is well-understood. And for many patients, PRP produces exactly the improvement they are looking for.
For others, it does not — or does not do so completely. The reason is partly biological and partly procedural. Standard PRP preparation concentrates whole platelets, whose growth factors are released when they activate upon injection into tissue. The concentration of growth factors available depends on the patient's individual platelet count, the efficiency of centrifugation, and the degree of platelet activation achieved. These variables mean that the biological potency of one patient's PRP differs from another's — and in some patients, the concentration of active growth factors delivered falls short of the therapeutic threshold that produces significant clinical change.
GFC addresses this directly. The additional preparation steps involved — platelet activation and lysis before extraction, followed by further concentration of the growth factor-rich supernatant — release all the growth factor content from the platelets and concentrate it specifically, producing a clear solution of active growth factors at a level above what standard PRP achieves. The inflammatory and pro-coagulant platelet components that are not therapeutically relevant are left behind. What remains is the precise biological payload that produces the response — purified, concentrated, and ready.
What GFC Actually Does
The preparation of GFC begins identically to PRP — a blood draw of approximately 20–30ml, followed by centrifugation to concentrate the platelet-rich plasma fraction. Where the two processes diverge is at the next step. Rather than activating the platelets at the point of injection, GFC preparation activates and lyses the platelets in the laboratory — mechanically releasing the entire contents of their alpha granules into the surrounding plasma. The growth factor-rich supernatant produced by this lysis is then extracted and further concentrated, producing a solution that contains PDGF, VEGF, EGF, TGF-β, IGF-1, and other regenerative molecules at a significantly higher concentration than the activated PRP produced by standard preparation. The pro-inflammatory and pro-coagulant components of the platelet membrane — which are not relevant to the regenerative response — are removed in the same step.
The clinical result of delivering a higher and more consistent growth factor concentration is more predictable and more significant biological stimulation at the treatment site. Fibroblasts and dermal cells receive a stronger growth signal. Collagen synthesis and cellular proliferation are activated more completely. And because the concentration is determined by the preparation process rather than the individual patient's platelet biology, the treatment produces consistent outcomes across patients — which standard PRP, subject to individual biological variability, cannot always guarantee.
Clinical Applications
What We Use It For at Ministry of Skin
For skin rejuvenation, GFC is delivered via the microneedling platform — applied to the skin through the micro-channels created by the needling procedure, penetrating the dermis at a depth and efficiency that topical application cannot achieve. The higher growth factor concentration of GFC compared to standard PRP produces a more potent stimulation of collagen synthesis, cellular renewal, and the overall biological quality of the dermal environment — with progressive improvement in skin firmness, luminosity, and texture reflecting the greater biological activity initiated at each session.
For acne scar revision, GFC is applied to the treatment area immediately following MNRF or fractional laser sessions — delivered through the micro-channels created by the device to amplify the healing and collagen-forming response initiated by the procedure. The growth factor stimulation provided by GFC in this context accelerates the transition from acute healing to active regeneration, improves the quality of new collagen formed in the treated scar site, and consistently enhances the outcome of the primary scar treatment session. For patients undertaking an acne scar programme at Ministry of Skin, the incorporation of GFC at each session is one of the most clinically meaningful ways to deepen the result.
For post-procedure recovery, GFC applied following laser resurfacing, MNRF, or chemical peel sessions reduces recovery time and improves the quality of healing tissue — not by suppressing the inflammatory response but by supporting the repair mechanisms that determine the quality of the final result. Patients who incorporate GFC into their post-procedure protocol consistently report faster resolution of post-treatment redness and sensitivity, and a more significant outcome in the treated area — reflecting the enhanced biological activity that a concentrated growth factor environment enables during the critical healing window.
For anti-ageing and skin quality, GFC stimulates fibroblast activity, collagen synthesis, and dermal renewal across the treated area — producing improvements in skin firmness, elasticity, and surface texture that develop progressively over the weeks following each session. For patients whose primary concern is the early structural changes of skin ageing — fine lines, loss of density, declining skin quality — GFC delivered through microneedling represents one of the most clinically productive autologous biological treatments available.
Results, Realistic Expectations, and When to Expect Them
GFC results develop progressively — the growth factor-initiated biological processes unfolding over weeks rather than days, with the most significant improvement visible at 4–8 weeks following each session as the collagen and cellular changes they prompted mature. For skin rejuvenation and anti-ageing, most patients notice improved luminosity and skin quality within 2–3 weeks of their first session, with continued improvement in firmness and texture developing through the course. For acne scar revision and post-procedure recovery, the benefit is most visible in the quality and speed of healing following the primary treatment — and in the degree of improvement seen at the 8–12 week outcome assessment.
A standard GFC programme at Ministry of Skin involves 3–4 sessions spaced 4–6 weeks apart, with maintenance every 3–6 months thereafter. The patients who achieve the most consistent results are those who complete the full initial course — because the biological improvement GFC produces is cumulative, each session building on the foundation established by the last.
Clients
Testimonials
Frequently Asked Questions
Both are autologous biological treatments prepared from your own blood, but GFC uses an additional activation and lysis step that releases all growth factor content from the platelets and concentrates the growth factor-rich supernatant specifically — producing a higher, more consistent growth factor concentration than standard PRP and removing inflammatory platelet components that are not therapeutically necessary. The result is a more potent biological stimulus with more predictable skin outcomes. For patients who have had PRP without achieving the skin improvement they hoped for, GFC is consistently the more productive clinical step.
Yes. GFC is used at Ministry of Skin as an adjunct to MNRF and fractional laser resurfacing for acne scar revision — applied immediately after the primary procedure to amplify the healing and collagen-remodelling response. The higher growth factor concentration accelerates the transition from acute healing to active regeneration, improves the quality of new collagen formed in the scar site, and consistently enhances the final outcome of the primary treatment. For patients undergoing a structured acne scar programme, GFC at each session is one of the most clinically meaningful ways to deepen the result.
A standard course for skin rejuvenation involves 3–4 sessions spaced 4–6 weeks apart, with maintenance every 3–6 months thereafter. Results continue to develop between sessions and for 6–8 weeks following each one — the biological process initiated by each session continuing independently after the growth factors themselves have been metabolised. The patients who achieve the most consistent results are those who complete the full initial course, as the biological improvement GFC produces is cumulative.
Yes — and at Ministry of Skin the combination is used for patients seeking the most comprehensive biological regenerative skin programme available. GFC and Exosome therapy work through genuinely complementary mechanisms: GFC delivers concentrated growth factors that bind to cell surface receptors and initiate regenerative signalling from the outside; Exosomes are taken up intracellularly, delivering growth factors and microRNA at a biological depth that surface receptor signalling cannot reach. The combination addresses both dimensions of the skin's regenerative response simultaneously — and for patients with significant skin rejuvenation or acne scar goals, it represents the most advanced autologous biological programme currently available.
GFC delivered via microneedling involves minimal downtime. Skin appears mildly flushed or pink immediately after the session, typically settling within 24–48 hours. Sun protection is essential in the days following treatment. Most patients return to normal activity the following day. When GFC is used as a post-procedure adjunct following MNRF or laser resurfacing, the overall recovery period of the primary treatment is often meaningfully reduced — with faster resolution of redness and sensitivity compared to the primary procedure without GFC support.